Distinguished medical researcher Professor Anne Kelso AO has been appointed the new CEO of the National Health and Medical Research Council.
The Minister for Health, Sussan Ley says Professor Kelso will take up her new position with the NHMRC in April.
“Professor Kelso’s distinguished career in medical research and her track record in internationally competitive research in immunology and influenza make her an ideal choice to head up the NMHRC,” Minister Ley says.
“Professor Kelso’s experience and expertise will be a great asset to Australia’s leading expert body for health and medical research and help Australia build on its reputation as a world leader in medical innovation.”
Complementary Medicines Australia’s CEO Carl Gibson says the appointment is a commendable step in driving the agenda of the NHMRC.
“With Professor Kelso set to take the reins at NHMRC in April, CMA looks forward to mature health and research policy discourse in relation to complementary medicines, and is keen to work with Professor Kelso and her team to significantly, and in a cost effective manner, contribute to quality research that improves the population health outcomes of the nation.”
“The Australian complementary medicines industry continues to invest in clinical trials, building on a growing evidence base, which is a remarkable achievement given the lack of IP protection currently afforded to those investing in this field. Continuing government support is needed to ensure the sustainability of this vital work, and the NHMRC will play a great role in encouraging this research,” says Gibson.
Prof Kelso obtained a Bachelor of Science (Honours) and PhD from the University of Melbourne and has developed significant global health experience and networks through her work with the World Health Organization (WHO).
Prof Kelso, through her previous role as director of the WHO Collaborating Centre on Influenza, worked on surveillance and vaccine policy relating to pandemic viruses and provided technical advice to ministers of health throughout the Asia-Pacific region.
She was also the director of the Co-operative Research Centre for Vaccine Technology from 2000 to 2006.
Prof Kelso will succeed Professor Warwick Anderson AO as CEO of the NHMRC.